Stonepine Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100,000	Closed	-$1.02M	–	73
2025 Q1	$1.02M	Buy	+100,000	New	+$1.02M	0.99%	22